Stem cell-derived dopaminergic neurons rescue motor defects in Parkinsonian monkeys
Parkinson's disease is a degenerative disorder of the central nervous system that is characterized by tremors, rigidity, slowness of movement, and difficulty walking. It is caused by loss of the neurons that produce the neurotransmitter ...
Parkinson's & Movement disorders
Dec 03, 2012 |
5 / 5 (1) |
0
Boosting immune responses against leukaemia
(Medical Xpress)—In the first of its kind, a translational study undertaken at the Malaghan Institute of Medical Research has revealed that boosting the activity of a rare type of immune cell could be an ...
Cancer
Nov 21, 2012 |
5 / 5 (1) |
0
Groundbreaking study that may change transplant practices
Researchers from John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's 50 best cancer centers, played an important role in a study published in the New England Journal of Medicine on Oct ...
Medical research
Nov 20, 2012 |
not rated yet |
0
Brain displays an intrinsic mechanism for fighting infection
(Medical Xpress)—White blood cells have long reigned as the heroes of the immune system. When an infection strikes, the cells, produced in bone marrow, race through the blood to fight off the pathogen. ...
Medical research
Nov 19, 2012 |
5 / 5 (3) |
2
|
Umbilical cord cells outperform bone marrow cells in repairing damaged hearts
A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), ...
Medical research
Nov 15, 2012 |
5 / 5 (2) |
0
|
Study: Stem cells from strangers can repair hearts
Researchers are reporting a key advance in using stem cells to repair hearts damaged by heart attacks. In a study, stem cells donated by strangers proved as safe and effective as patients' own cells for helping ...
Cardiology
Nov 06, 2012 |
4.5 / 5 (2) |
0
Therapy with bone marrow-derived stem cells does not improve short-term recovery after heart attack
Administering to patients stem cells derived from their own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported ...
Cardiology
Nov 05, 2012 |
4 / 5 (1) |
0
|
Synribo approved to treat rare leukemia
(HealthDay)—Synribo (omacetaxine mepesuccinate) has been approved by the U.S. Food and Drug Administration to treat a rare blood and bone marrow disease called chronic myelogenous leukemia (CML).
Cancer
Oct 26, 2012 |
not rated yet |
0
Duke research team identifies a potent growth factor for blood stem cells
Duke Medicine researchers studying the interaction of blood stem cells and the niche where they reside have identified a protein that may be a long-sought growth factor for blood stem cells.
Medical research
Oct 23, 2012 |
5 / 5 (1) |
0
|
Insights into rare immune cells that keep blood stem cells in a youthful state may lead to better treatments
Hiding deep inside the bone marrow are special cells. They wait patiently for the hour of need, at which point these blood forming stem cells can proliferate and differentiate into billions of mature blood ...
Immunology
Oct 22, 2012 |
not rated yet |
0
|
Father of bone marrow transplant is dead at 92
E. Donnall Thomas, a physician who pioneered bone marrow transplants and later won the 1990 Nobel Prize in medicine, has died in Seattle at age 92.
Other
Oct 21, 2012 |
not rated yet |
0
No survival advantage with peripheral blood stem cells versus bone marrow
(Medical Xpress)—Claudio Anasetti, M.D., chair of the Department of Blood & Marrow Transplant at Moffitt Cancer Center, and colleagues from 47 research sites in the Blood and Marrow Transplant Clinical Trials Network conducted ...
Medical research
Oct 19, 2012 |
not rated yet |
0
Leading bone marrow transplant expert recommends significant change to current practice
One of the world's leading bone marrow transplant experts is recommending a significant change to current transplant practice for patients who need marrow or adult stem cells from an unrelated donor to treat hematologic malignancies. ...
Other
Oct 17, 2012 |
not rated yet |
0
|
Researcher pieces together AML prognosis puzzle
When patients suffering from Acute Myeloid Leukemia (AML) express high levels of the gene, MN1, an already aggressive leukemia is accelerated and shortens survival time. While that's a known fact, the mechanisms involved ...
Cancer
Oct 15, 2012 |
not rated yet |
0
|
DNA method can provide more effective treatment of childhood cancer
After leukaemia and brain tumours, neuroblastoma is the most common form of cancer to affect children. A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, has studied a DNA method which is now used for ...
Cancer
Oct 15, 2012 |
5 / 5 (1) |
0
